ArticleThe Indian journal of medical research2025
Expression of circulating p38 inhibited cutaneous squamous cell carcinoma-associated long non-coding RNA in rheumatoid arthritis: A descriptive study.
Article in The Indian journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objectives Rheumatoid arthritis (RA) is a chronic inflammatory disease characterised by joint destruction. Long non-coding RNAs (lncRNAs) have emerged as key regulators in RA pathogenesis. This study explores the serum expression of p38-inhibited cutaneous squamous cell carcinoma-associated lncRNA (PICSAR lncRNA) as a potential non-invasive biomarker for RA. Methods PICSAR lncRNA expression was measured in serum samples from 36 individuals with RA and 20 healthy individuals using qRT-PCR over a 24 h time course. Correlation analyses with demographic and biochemical parameters, American College of Rheumatology (ACR) scores, and ROC analysis were conducted to evaluate the diagnostic potential of PICSAR lncRNA. Results We observed significant upregulation of PICSAR lncRNA in individuals with RA at 0 h (448.9±358.6, P=0.0059) and 6 h (202.0±121.2, P=0.0005) compared to healthy individuals, with stable levels maintained up to 24 h. The ROC analysis yielded a substantial AUC value of 0.74 for PICSAR lncRNA in individuals with RA. In females with RA, PICSAR lncRNA levels showed a positive correlation with ACR scores and a negative correlation with age. Interpretation & conclusions PICSAR lncRNA is implicated in RA pathogenesis and may serve as a potential non-invasive diagnostic biomarker for RA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.